It is a truth universally acknowledged that a man in possession of a good e-ink display, must be in want of a weather station ...

Escape Room Lockbox with the Cheap Yellow Display. You may have heard of the “cheap yellow display” (CYD), so-called ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

Follow ZDNET: Add us as a preferred source on Google. When I walked into a conference room in Google's San Francisco building last week, I expected to find the typical tech briefing setup with rows of ...

Cylembio combined with pembrolizumab showed improved median progression-free survival, especially in PD-L1–negative tumors, but narrowly missed statistical significance. The vaccine demonstrated a ...

They look, move and even smell like the kind of furry Everglades marsh rabbit a Burmese python would love to eat. But these bunnies are robots meant to lure the giant invasive snakes out of their ...

IO Biotech's phase 3 melanoma trial showed a strong PFS benefit, especially in true 1st-line and PD1-negative patients, despite narrowly missing statistical significance. I believe the FDA should ...

IO Biotech’s cancer vaccine has “narrowly” failed to beat Merck's blockbuster oncology drug Keytruda in a phase 3 melanoma trial, but the company remains hopeful of a path to approval. The New ...

NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company, today announced the company will hold a conference call and webcast on Monday, August ...